SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (910)11/16/1997 3:32:00 PM
From: Steve Harmon  Read Replies (1) of 2742
 
Jim,

I agree with you on Bluestone. Only 3 1/2 months left on the Bluestone contract. I hear from a source at Bluestone that John Kluge is a silent partner there.

Just stating that CIST's mgt. by initiating a small buyback could on their own eliminate MARK CAPITAL's remaining position of less than 500,000 shares which is keeping CIST at these SILLY levels.

When Bluestone makes their move they will probably gobble up those shares on the cheap for their clients. (Probably negotiating a price for that remaining block now.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News